lobeline has been researched along with Amphetamine Abuse in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crooks, PA; Dwoskin, LP; Kangiser, MM; Stairs, DJ; Zheng, G | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Lee, NR; Zheng, G | 1 |
| Crooks, PA; Dwoskin, LP; Nickell, JR; Siripurapu, KB; Vartak, A | 1 |
| Crooks, PA; Ding, D; Dwoskin, LP; Nickell, JR | 1 |
| Crooks, PA; Deaciuc, G; Dwoskin, LP; Krishnamurthy, S; Nickell, JR; Norrholm, S; Siripurapu, KB; Zheng, G | 1 |
| Bardo, MT; Beckmann, JS; Crooks, PA; Denehy, ED; Dwoskin, LP; Horton, DB; Nickell, JR; Siripurapu, KB; Vartak, A | 1 |
| Crooks, PA; Dwoskin, LP; Horton, DB; Siripurapu, KB; Zheng, G | 1 |
| Daniels, WM; Dimatelis, JJ; Russell, VA; Stein, DJ | 1 |
| Alvers, KM; Bardo, MT; Beckmann, JS; Crooks, PA; Dwoskin, LP; Zheng, G | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Harrod, SB; Neugebauer, NM; Stairs, DJ | 1 |
| Eshleman, AJ; Janowsky, A; Johnson, RA; Wilhelm, CJ | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Harrod, SB; Klebaur, JE | 1 |
| Crooks, PA; Dwoskin, LP | 1 |
2 review(s) available for lobeline and Amphetamine Abuse
| Article | Year |
|---|---|
The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.
Topics: Amphetamine-Related Disorders; Animals; Drug Delivery Systems; Drug Discovery; Humans; Lobeline; Methamphetamine; Protein Binding; Treatment Outcome; Vesicular Monoamine Transport Proteins | 2014 |
A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse.
Topics: Amphetamine-Related Disorders; Central Nervous System; Dopamine; Forecasting; Ganglionic Stimulants; Humans; Lobeline; Methamphetamine | 2002 |
11 other study(ies) available for lobeline and Amphetamine Abuse
| Article | Year |
|---|---|
Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Lobeline; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Substance-Related Disorders; Varenicline | 2018 |
New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders.
Topics: Administration, Oral; Amphetamine-Related Disorders; Animals; Cardiotoxicity; Disease Models, Animal; Dopamine; Ether-A-Go-Go Potassium Channels; Humans; Lobeline; Locomotion; Male; Methamphetamine; Molecular Structure; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Treatment Outcome; Vesicular Monoamine Transport Proteins | 2018 |
Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2.
Topics: Amphetamine-Related Disorders; Animals; Binding Sites; Dopamine; Humans; In Vitro Techniques; Kinetics; Lobeline; Methamphetamine; Rats; Structure-Activity Relationship; Synaptic Vesicles; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2015 |
Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Evaluation, Preclinical; Lobeline; Male; Methamphetamine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Synaptic Vesicles; Synaptosomes; Vesicular Monoamine Transport Proteins | 2010 |
The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aconitine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Cell Membrane; Conditioning, Operant; Corpus Striatum; Dopamine; Drug Tolerance; Lobeline; Male; Methamphetamine; Nicotine; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Self Administration; Synaptic Vesicles; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2010 |
Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.
Topics: Amphetamine-Related Disorders; Animals; Binding, Competitive; Corpus Striatum; Data Interpretation, Statistical; Dopamine; Dopamine Uptake Inhibitors; Kinetics; Lobeline; Male; Methamphetamine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Synaptic Vesicles; Synaptosomes; Vesicular Monoamine Transport Proteins | 2011 |
The effects of lobeline and naltrexone on methamphetamine-induced place preference and striatal dopamine and serotonin levels in adolescent rats with a history of maternal separation.
Topics: Age Factors; Amphetamine-Related Disorders; Animals; Animals, Newborn; Corpus Striatum; Female; Lobeline; Male; Maternal Deprivation; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Stress, Psychological; Vesicular Monoamine Transport Proteins | 2012 |
The effect of VMAT2 inhibitor GZ-793A on the reinstatement of methamphetamine-seeking in rats.
Topics: Amphetamine-Related Disorders; Animals; Drug-Seeking Behavior; Illicit Drugs; Lobeline; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Vesicular Monoamine Transport Proteins | 2012 |
Lobelane decreases methamphetamine self-administration in rats.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Infusions, Intravenous; Lobeline; Male; Methamphetamine; Molecular Structure; Motor Activity; Rats; Rats, Sprague-Dawley; Self Administration; Sucrose | 2007 |
Lobeline effects on tonic and methamphetamine-induced dopamine release.
Topics: Amphetamine-Related Disorders; Cell Line; Cocaine; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Lobeline; Methamphetamine; Nomifensine; Reserpine; Vesicular Monoamine Transport Proteins | 2008 |
Lobeline attenuates d-methamphetamine self-administration in rats.
Topics: Amphetamine-Related Disorders; Animals; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Lobeline; Male; Methamphetamine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Sucrose | 2001 |